Skip to main navigation
logo
SAB Biotherapeutics Logo
  • ABOUT US
    Company Profile Executive Management Board of Directors Clinical Advisory Board
  • OUR PIPELINE
  • OUR SCIENCE
  • FOR PATIENTS
  • INVESTORS & MEDIA
    Overview News & Press Releases Presentations Events SEC Filings Stock Quote & Chart Senior Management Board of Directors Board Committees Corporate Governance Clinical Advisory Board Analyst Coverage RSS Feeds Contact Us
  • CONTACT US

SEC Filing Details

Breadcrumb

  1. Home
  2. Investors
  3. 8-K

Document Details

Form
8-K
Filing Date
Mar 19, 2026
Document Date
Mar 17, 2026
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
SAB Biotherapeutics
Issuer
SAB BIOTHERAPEUTICS, INC.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
XML - XBRL INSTANCE DOCUMENT

Shareholder Tools

  • Print Page
  • Email Alerts
  • RSS
  • Investor FAQs
SAb Biotherapeutics logo

Social Media Menu

  • ©2026 SAb Biotherapeutics, Inc.
  • All Rights Reserved
  • Terms & Conditions
  • Privacy Policy
  • Conflict of Interest Policy
  • Contact Us